Telang, Nitin (2018) Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer. Oncol Lett 15:642-648
|
Telang, Nitin (2015) Putative cancer-initiating stem cells in cell culture models for molecular subtypes of clinical breast cancer. Oncol Lett 10:3840-3846
|
Telang, Nitin; Katdare, Meena (2011) Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review). Oncol Rep 25:1195-201
|
Protiva, Petr; Mason, Joel B; Liu, Zhenhua et al. (2011) Altered folate availability modifies the molecular environment of the human colorectum: implications for colorectal carcinogenesis. Cancer Prev Res (Phila) 4:530-43
|
Cunningham-Rundles, Susanna; Ahrné, Siv; Johann-Liang, Rosemary et al. (2011) Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients 3:1042-70
|
Hsieh, Tze-chen; Wu, Joseph M (2010) Resveratrol: Biological and pharmaceutical properties as anticancer molecule. Biofactors 36:360-9
|
Cheng, Yu-Wei; Idrees, Kamran; Shattock, Richard et al. (2010) Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer. Int J Cancer 127:568-77
|
Peoples, John Denton; Cheung, Sandy; Nesin, Mirjana et al. (2009) Neonatal cord blood subsets and cytokine response to bacterial antigens. Am J Perinatol 26:647-57
|
Protiva, Petr; Cross, Heide S; Hopkins, Michael E et al. (2009) Chemoprevention of colorectal neoplasia by estrogen: potential role of vitamin D activity. Cancer Prev Res (Phila) 2:43-51
|
Tan, Chen; Cai, Li-Qun; Wu, Wendy et al. (2009) NSC606985, a novel camptothecin analog, induces apoptosis and growth arrest in prostate tumor cells. Cancer Chemother Pharmacol 63:303-12
|
Showing the most recent 10 out of 28 publications